Ribavirin for treating Crimean Congo haemorrhagic fever Unchanged
Ribavirin for treating Crimean Congo haemorrhagic fever Unchanged is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ribavirin for Treating Crimean Congo Haemorrhagic Fever Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434849/all/Ribavirin_for_treating_Crimean_Congo_haemorrhagic_fever_Unchanged. Accessed 02 February 2023.
Ribavirin for treating Crimean Congo haemorrhagic fever Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434849/all/Ribavirin_for_treating_Crimean_Congo_haemorrhagic_fever_Unchanged. Accessed February 2, 2023.
Ribavirin for treating Crimean Congo haemorrhagic fever Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434849/all/Ribavirin_for_treating_Crimean_Congo_haemorrhagic_fever_Unchanged
Ribavirin for Treating Crimean Congo Haemorrhagic Fever Unchanged [Internet]. In: Cochrane Abstracts. [cited 2023 February 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434849/all/Ribavirin_for_treating_Crimean_Congo_haemorrhagic_fever_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ribavirin for treating Crimean Congo haemorrhagic fever Unchanged
ID - 434849
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434849/all/Ribavirin_for_treating_Crimean_Congo_haemorrhagic_fever_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -